 |
With unrivalled expertise in immunology, 5 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q² Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic, and oncologic fields. Register now to discover Nexelis’ first-hand perspective on how to develop innovative, agile solutions in vaccine efficacy testing. This e-book will give you exclusive insights into best practises for constructing a robust assay including details on pseudotyped virus production, development of critical reagents, pseudotyped neutralization assay, achieving accuracy and precision and assays for humoral and cellular responses. |
